Literature DB >> 32315079

Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?

Giovanni Genovese1,2, Cristiana Colonna1, Angelo V Marzano1,2.   

Abstract

It has been reported that the novel coronavirus disease (COVID-19) may be associated with a papulovesicular skin eruption predominantly involving the trunk. We hereby present a case of COVID-19-associated varicella-like exanthem in an 8-year-old girl with mild systemic symptoms.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; infection; pediatric; viral exanthem

Mesh:

Year:  2020        PMID: 32315079      PMCID: PMC7264614          DOI: 10.1111/pde.14201

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.997


CASE REPORT

On March 21, 2020, an 8‐year‐old girl from Milan (Lombardy region, Italy) presented to our outpatient service for a 3‐day history of an asymptomatic papulovesicular skin eruption. On physical examination, there were about forty erythematous papules and few vesicles scattered bilaterally and symmetrically on the trunk. Limbs, face, and genitals as well as mucous membranes were spared. The lesions were initially erythematous papules (Figure 1A,B), some of which showed a tendency to superficial vesiculation leading to crust formation. Medical history revealed that she was in good health except for a 6‐day history of mild cough. She had a history of varicella infection a year earlier. Routine blood tests, including complete blood count, liver and kidney function, and C‐reactive protein, showed no abnormalities except for mild thrombocytopenia (platelet count: 105 000/μL; range: 150 000/μL–400 000/μL).
Figure 1

A and B, Scattered erythematous papulovesicles on the trunk in a suspected COVID‐19 patient

A and B, Scattered erythematous papulovesicles on the trunk in a suspected COVID‐19 patient Based on the clinical findings, a diagnosis of viral exanthem was suspected. The patient's parents refused a skin biopsy. Two days later, the patient developed mild fever. On March 24, 2020, the patient's father, mother, and grandmother manifested fever and cough, and, on the same day, the patient and her family tested positive for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) via nasopharyngeal swab. The patient's grandmother was hospitalized for COVID‐19–associated pneumonia. The patient's skin lesions as well as systemic symptoms subsided without any therapy within 7 days, and platelet count reverted to normal. The patient was discharged to home isolation with her family, and no further systemic nor skin manifestations were reported.

DISCUSSION

COVID‐19, an infection due to SARS‐CoV‐2, arose in Wuhan (Hubei province), China, and quickly spread to Europe, becoming a public health emergency of global concern. The illness is characterized by a wide list of clinical manifestations, ranging from respiratory symptoms such as dry cough and dyspnea to non‐respiratory symptoms including myalgia and diarrhea. Loss of smell and taste has also been reported. Cutaneous manifestations associated with COVID‐19 have been recently reported in adults by Joob and coworkers, who described a patient from Thailand with a petechial rash initially misdiagnosed as dengue, and by Recalcati who reported on hospitalized patients in Italy with erythematous rash (n = 14), widespread urticaria (n = 3), and varicella‐like vesicles (n = 1). Two of the authors of the present paper (GG and AVM) have reported a series of 21 adult patients and one child (who is the case described here in detail) with COVID‐19 who developed a varicella‐like rash predominantly involving the trunk, including 7 cases in which histology was obtained and findings were compatible with viral infection. Herein, we describe this varicella‐like exanthem as a possible COVID‐19–associated skin manifestation in children. In our patient, the latency time of the development of rash after cough's onset was three days and the exanthem duration was seven days. Other skin manifestations and mucosal involvement as well as symptoms such as pruritus, pain, or burning were absent. Alternative diagnoses for such an eruption include varicella infection, which is unlikely based on prior infection, and insect bites, which are unlikely in the absence of pruritus. Even though our data do not prove that this rash is caused by or definitively associated with COVID‐19, we suggest that papulovesicular eruptions be included in the spectrum of exanthems possibly associated with COVID‐19. Based on the features and early appearance, this varicella‐like exanthem could be a useful clue to suspect the diagnosis of COVID‐19 in asymptomatic and paucisymptomatic children, prompting microbiological investigation in these patients. Since COVID‐19 usually manifests without severe respiratory symptoms in children, the recognition of potential associated skin manifestations could avoid spreading of the infection in the population.
  5 in total

1.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

2.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.

Authors:  Jerome R Lechien; Carlos M Chiesa-Estomba; Daniele R De Siati; Mihaela Horoi; Serge D Le Bon; Alexandra Rodriguez; Didier Dequanter; Serge Blecic; Fahd El Afia; Lea Distinguin; Younes Chekkoury-Idrissi; Stéphane Hans; Irene Lopez Delgado; Christian Calvo-Henriquez; Philippe Lavigne; Chiara Falanga; Maria Rosaria Barillari; Giovanni Cammaroto; Mohamad Khalife; Pierre Leich; Christel Souchay; Camelia Rossi; Fabrice Journe; Julien Hsieh; Myriam Edjlali; Robert Carlier; Laurence Ris; Andrea Lovato; Cosimo De Filippis; Frederique Coppee; Nicolas Fakhry; Tareck Ayad; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-04-06       Impact factor: 2.503

3.  Varicella-like exanthem as a specific COVID-19-associated skin manifestation: Multicenter case series of 22 patients.

Authors:  Angelo Valerio Marzano; Giovanni Genovese; Gabriella Fabbrocini; Paolo Pigatto; Giuseppe Monfrecola; Bianca Maria Piraccini; Stefano Veraldi; Pietro Rubegni; Marco Cusini; Valentina Caputo; Franco Rongioletti; Emilio Berti; Piergiacomo Calzavara-Pinton
Journal:  J Am Acad Dermatol       Date:  2020-04-16       Impact factor: 11.527

4.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

5.  COVID-19 can present with a rash and be mistaken for dengue.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  5 in total
  46 in total

1.  COVID-19 cutaneous manifestations in children and adolescents: a systematic review.

Authors:  Ricardo Pasquini Neto; Felipe Antonio Torres Mazzo; Fernanda de Almeida Vieira; Gustavo de Souza Bueno; João Vitor Correa Previdi; Lara Rozetti da Silva; Nasthia Kreuz Baziulis da Silva; Joseph Lucius Jorizzo; Felipe Bochnia Cerci
Journal:  Rev Paul Pediatr       Date:  2022-06-10

2.  [Clinical features of coronavirus disease 2019 in children: a systemic review of severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019].

Authors:  Yang He; Jun Tang; Meng Zhang; Hao-Ran Wang; Wen-Xing Li; Tao Xiong; You-Ping Li; De-Zhi Mu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-08

3.  A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations.

Authors:  Niloufar Najar Nobari; Farnoosh Seirafianpour; Milad Dodangeh; Afsaneh Sadeghzadeh-Bazargan; Elham Behrangi; Samaneh Mozafarpoor; Azadeh Goodarzi
Journal:  Exp Dermatol       Date:  2021-05-24       Impact factor: 4.511

Review 4.  Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.

Authors:  Keyun Tang; Yuanzhuo Wang; Hanlin Zhang; Qingyue Zheng; Rouyu Fang; Qiuning Sun
Journal:  Dermatol Ther       Date:  2020-05-22       Impact factor: 2.851

Review 5.  A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19.

Authors:  Hoda Rahimi; Zohreh Tehranchinia
Journal:  Biomed Res Int       Date:  2020-07-05       Impact factor: 3.411

Review 6.  Skin disorders associated with the COVID-19 pandemic: A review.

Authors:  Jennifer Akl; Jessica El-Kehdy; Antoine Salloum; Anthony Benedetto; Paula Karam
Journal:  J Cosmet Dermatol       Date:  2021-07-01       Impact factor: 2.189

7.  Infectious-mononucleosis-like exanthema associated with COVID-19 in a child.

Authors:  Meryam Ferjani; Malek Ben Slimane; Taha Sayari; Yosra Hammi; Noureddine Litaiem; Ouns Naija; Faten Zeglaoui; Tahar Gargah
Journal:  Clin Case Rep       Date:  2021-07-23

Review 8.  Skin manifestations of COVID-19 in children: Part 2.

Authors:  D Andina; A Belloni-Fortina; C Bodemer; E Bonifazi; A Chiriac; I Colmenero; A Diociaiuti; M El-Hachem; L Fertitta; D van Gysel; A Hernández-Martín; T Hubiche; C Luca; L Martos-Cabrera; A Maruani; F Mazzotta; A D Akkaya; M Casals; J Ferrando; R Grimalt; I Grozdev; V Kinsler; M A Morren; M Munisami; A Nanda; M P Novoa; H Ott; S Pasmans; C Salavastru; V Zawar; A Torrelo
Journal:  Clin Exp Dermatol       Date:  2020-11-09       Impact factor: 4.481

Review 9.  Cutaneous manifestations of SARS-CoV-2 infection: a clinical update.

Authors:  P Gisondi; S PIaserico; C Bordin; M Alaibac; G Girolomoni; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-20       Impact factor: 9.228

10.  Rash as a presenting complaint in a child with COVID-19.

Authors:  Anna Klimach; Jordan Evans; Jennifer Stevens; Nikola Creasey
Journal:  Pediatr Dermatol       Date:  2020-07-16       Impact factor: 1.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.